Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 42, Issue 3, Pages 771-782
Publisher
Wiley
Online
2012-04-09
DOI
10.1002/eji.201141835
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease-Modifying Agents in the Treatment of Multiple Sclerosis: A Review of Long-Term Outcomes
- (2012) Oleksandra Katrych et al. CNS & Neurological Disorders-Drug Targets
- Comparative study of clinical grade human tolerogenic dendritic cells
- (2011) M Naranjo-Gómez et al. Journal of Translational Medicine
- Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis
- (2010) R. A. Harry et al. ANNALS OF THE RHEUMATIC DISEASES
- Apoptotic cell-based therapies against transplant rejection: role of recipient’s dendritic cells
- (2010) Adrian E. Morelli et al. APOPTOSIS
- Therapeutic Approaches to Multiple Sclerosis
- (2010) Jochen C. Ulzheimer et al. BIODRUGS
- T cell recognition of self-antigen presenting cells by protein transfer assay reveals a high frequency of anti-myelin T cells in multiple sclerosis
- (2010) Bouchaib Bahbouhi et al. BRAIN
- Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes
- (2010) S. Marin-Gallen et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis
- (2010) L. Grau-López et al. EUROPEAN JOURNAL OF NEUROLOGY
- Induction of pathogenic cytotoxic T lymphocyte tolerance by dendritic cells: a novel therapeutic target
- (2010) Dipender Gill et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation
- (2010) Lars E. Bartels et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Development of Dendritic Cell-Based Immunotherapy for Autoimmunity
- (2010) Catharien M. U. Hilkens et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- IL-10/TGF-β-Treated Dendritic Cells, Pulsed with Insulin, Specifically Reduce the Response to Insulin of CD4+ Effector/Memory T Cells from Type 1 Diabetic Individuals
- (2010) Honorio Torres-Aguilar et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4+CD25+CD127low/−FoxP3+ T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment
- (2010) B. Soldevila et al. JOURNAL OF VIRAL HEPATITIS
- Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis
- (2010) Halina Bartosik-Psujek et al. Multiple Sclerosis Journal
- A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
- (2010) J. M. Burton et al. NEUROLOGY
- Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis
- (2009) Hania Kebir et al. ANNALS OF NEUROLOGY
- Myelin peptides in multiple sclerosis
- (2009) L. Grau-López et al. AUTOIMMUNITY REVIEWS
- Immunomodulatory effects of Vitamin D in multiple sclerosis
- (2009) J. Correale et al. BRAIN
- Dendritic Cell Therapy of High-Grade Gliomas
- (2009) Stefaan Van Gool et al. BRAIN PATHOLOGY
- Phenotypic and functional markers for 1α,25-dihydroxyvitamin D3-modified regulatory dendritic cells
- (2009) A. W. Pedersen et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells
- (2009) Klára Sochorová et al. CLINICAL IMMUNOLOGY
- Induction of Treg by monocyte-derived DC modulated by vitamin D3or dexamethasone: Differential role for PD-L1
- (2009) Wendy W. J. Unger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Dendritic Cell-Based Cancer Gene Therapy
- (2009) Evelien L.J.M. Smits et al. HUMAN GENE THERAPY
- Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists
- (2009) Luciano Adorini et al. HUMAN IMMUNOLOGY
- Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
- (2008) Hideki Garren et al. ANNALS OF NEUROLOGY
- Tolerogenic dendritic cells for autoimmune disease and transplantation
- (2008) A W Thomson et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis
- (2008) Adi Vaknin-Dembinsky et al. JOURNAL OF NEUROIMMUNOLOGY
- Antigen-specific therapies in MS — Current concepts and novel approaches
- (2008) Andreas Lutterotti et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started